Thiosemicarbazones and fluorquinolones are a class of compounds presenting a wide range of pharmacological activities. In the present work a study of thiosemicarbazones and their Mn(II) and Co(II) complexes with potential anti parasite and antitumoral activities was carried out along with an investigation of Mn(II) and Co(II) complexes of norfloxacin and sparfloxacin with antimicrobial activity. N(4)-methyl thiosemicarbazones derived from 4-nitrobenzaldehyde (H4NO2Fo4M), 4-nitroacetophenone (H4NO2Ac4M) and 4-nitrobenzophenone (H4NO2Bz4M) and their Mn(II) and Co(II) complexes, [Mn(H4NO2Fo4M)2Cl2], [Mn(H4NO2Ac4M)2Cl2], [Mn(H4NO2Bz4M)2Cl2], [Co(H4NO2Fo4M)2Cl2], [Co(H4NO2Ac4M)2Cl2], [Co(H4NO2Bz4M)2Cl2], were obtained and characterized. The crystal structure of H4NO2Fo4M has been determined. Electrochemical studies have shown that the Ar-NO2, one of the proposed intermediates in the mechanism of action of nitro-containing anti-trypanosomal drugs, is formed at approximately -1.00 V in the free thiosemicarbazones as well as in their corresponding Mn(II) complexes, suggesting their potential to act as antitrypanosomal drugs. The natural fluorescence of H4NO2Fo4M, H4NO2Ac4M, H4NO2Bz4M and Mn(II) and Co(II) complexes provides a way to identify and to monitor their concentration in biological systems. The toxicity of the thiosemicarbazones and their Mn(II) complexes against Artemia salina was assayed as a prescreening for antitumoral action. The low values of CL50;48h obtained for the studied compounds in this assay indicate that they could present antineoplastic properties. One of the major problems in the clinical treatment of infection by bacteria is the appearance of resistance and therefore the search for new drugs is extremely important. In many cases resistance mechanisms recognize the ligand but cannot recognize its metal complex. In the present work Mn(II) and Co(II) complexes of norfloxacin and sparfloxacin, [MnCl2(NOR)(H2O)2], [CoCl2(NOR)(H2O)2], [MnCl2(ESPAR)(H2O)2] and [CoCl2(ESPAR)(H2O)2] were obtained and their antibacterial activity against Staphylococcus aureus has been tested. We believe that this work contributes for a better knowledge of the chemistry of thiosemicarbazones and fluorquinolones and their pharmacological properties.